CONTENTS ... • Ethical, regulatory and legal issues • Commercialization, funding and economics of

  • View
    0

  • Download
    0

Embed Size (px)

Text of CONTENTS ... • Ethical, regulatory and legal issues • Commercialization, funding and...

  • For more information go to www.future-science-group.com2

  • 3For more information visit www.future-science-group.com

    CONTENTS

    Our Journal Portfolio ...............................................................................................

    Audience ...............................................................................................

    Future Medicine At-A-Glance ...............................................................................................

    Future Science At-A-Glance ...............................................................................................

    New to Future Medicine ...............................................................................................

    Cutting-Edge Websites ...............................................................................................

    Subject Collections ...............................................................................................

    Information for Librarians ...............................................................................................

    Institutional Trials ...............................................................................................

    FSG Connect ...............................................................................................

    Testimonials ...............................................................................................

    13

    14

    15

    4

    5

    6

    7

    8

    9

    10

    12

    https://www.future-science-group.com/

  • 4 For more information visit www.future-science-group.com

    OUR JOURNAL PORTFOLIO

    Future Science Group (FSG) is an independent publisher, based in London, with an expanding and diverse group of journals in cutting-edge areas of postgenomic scientific and medical information. FSG houses two imprints; Future Medicine and Future Science. All journals are peer reviewed and many are also indexed on MEDLINE, Clarivate’s Science Citation Index Expanded, EMBASE, Chemical Abstracts and Scopus.

    All publications are:

    ORIGINAL AND TIMELY Blending commissioned and unsolicited content, whether reviews, research or commentaries, to ensure that readers are kept comprehensively up-to-date on the latest advances and techniques in bioscience and clinical practice, whatever their discipline.

    SUPPORTED BY STRONG EDITORIAL STANDARDS All journals are underpinned by robust double-blind peer review ensuring only articles of the highest quality are published. Authors benefit from a supportive in-house editorial team, taking them from pre-submission enquiries, right through to publication and beyond.

    VISIBLE AND ACCESSIBLE GLOBALLY To ensure 24/7 access and maximum discoverability, all of our titles are hosted by Atypon on newly launched websites.

    https://www.future-science-group.com/

  • For more information go to www.future-science-group.com 5

    AUDIENCE

    For more information visit www.future-science-group.com 5

    https://www.future-science-group.com/

  • 6 For more information visit www.future-science-group.com

    FUTURE MEDICINE AT-A-GLANCE

    Journal MEDLINE-indexed Impact Factor (2016) Frequency (per year)

    (NEW) Bioelectronics in Medicine No n/a 4

    Biomarkers in Medicine Yes 2.02 12

    Breast Cancer Management No n/a Rolling

    CNS Oncology Yes n/a Rolling

    Colorectal Cancer No n/a Rolling

    Concussion No n/a Rolling

    Epigenomics Yes 4.54 12

    Future Cardiology Yes n/a 6

    Future Microbiology Yes 3.37 16

    Future Neurology No n/a 4

    Future Oncology Yes 2.13 30

    Future Virology No 0.96 12

    Hepatic Oncology No n/a Rolling

    Immunotherapy Yes 2.72 16

    International Journal of Endocrine Oncology No n/a Rolling

    International Journal of Hematologic Oncology No n/a Rolling

    Journal of 3D Printing in Medicine No n/a 4

    Journal of Comparative Effectiveness Research Yes 1.20 8

    Lung Cancer Management No n/a Rolling

    Melanoma Management No n/a Rolling

    Nanomedicine Yes 4.73 24

    Neurodegenerative Disease Management Yes n/a 6

    Pain Management Yes n/a 6

    Personalized Medicine No 1.01 6

    Pharmacogenomics Yes 2.35 18

    Regenerative Medicine Yes 2.87 8

    = Open Access

    https://www.future-science-group.com/

  • 7For more information visit www.future-science-group.com

    FUTURE SCIENCE AT-A-GLANCE

    Journal MEDLINE-indexed Impact Factor (2016) Frequency (per year)

    Bioanalysis Yes 2.67 24

    Future Medicinal Chemistry Yes 3.56 24

    Future Science OA PMC-indexed n/a Rolling

    International Journal of Pharmacokinetics No n/a 4

    Pharmaceutical Patent Analyst Yes n/a 6

    Therapeutic Delivery Yes n/a 12

    = Open Access

    PMC = Pubmed Central

    https://www.future-science-group.com/

  • 8 For more information visit www.future-science-group.com

    NEW TO FUTURE MEDICINE

    Bioelectronics in Medicine Providing a platform for the growing global network of bioelectricians to address the most important advances and challenges in this dynamic field. Through research, commentary and review, Bioelectronics in Medicine will deliver a critical overview of basic science, biotechnological developments and their therapeutic applications in human health.

    Frequency: 4 per year Editor-in-Chief: Professor Robert Shepherd, University of Melbourne, Australia

    COVERAGE INCLUDES: • The characterization of neural pathways affecting organs, functions and disease states • Computational and theoretical modelling • Device development and the miniaturization of bioelectronic devices • Novel materials for the development of bioelectronics • Biosensors in the context of bioelectronic tools • Advances in bioelectronic technology and their potential medical applications • The benefits of bioelectronic devices over traditional techniques • Pre-clinical and clinical testing of bioelectronic technology • Ethical, regulatory and legal issues • Commercialization, funding and economics of bioelectronic technology The journal welcomes unsolicited proposals.

    https://www.future-science-group.com/

  • 9For more information visit www.future-science-group.com

    CUTTING-EDGE WEBSITES

    We are delighted to announce the launch of our newly refurbished websites, www.futuremedicine.com and www.future-science.com.

    The sleek new websites were developed with the user experience in mind to really maximize the article reading experience, whatever the platform or device.

    Both include many new features to help users quickly and easily navigate the site to see the full journal and eBook portfolio, as well as new social capabilities, offering users a 1-click ability to share articles across their social networks.

    For existing users, we have bolted on this new front-end design to the existing back-end, so there is no need to create new accounts or profiles.

    Administrator capabilities and access rights also remain unchanged – making this a seamless transition.

    https://www.future-science-group.com/ www.futuremedicine.com https://www.future-science.com/

  • 10 For more information go to www.future-science-group.com

    SUBJECT COLLECTIONS

    DRUG R&D

    BIOPRINTING

    LOOKING FOR JOURNALS THAT COMPLEMENT EACH OTHER?

    The following journals have been grouped into our most popular journal packages, making it easier for you when looking for further publications to complement your existing subscriptions.

    https://www.future-science-group.com/

  • 11For more information go to www.future-science-group.com

    MOLECULAR MEDICINE

    IMMUNOLOGY

    NEUROLOGY

    https://www.future-science-group.com/

  • 12 For more information contact subscriptions@future-science-group.com

    INFORMATION FOR LIBRARIANS

    INSTITUTIONAL & ACADEMIC SUBSCRIPTIONS Academic pricing is set regardless of size or number of sites. All academic institutes receive 5 years of content.

    CORPORATE Corporate pricing is set depending on the size of the company and the number of sites. Corporate institutes receive 2 years of content (backfiles of content are available on request).

    CONSORTIA FSG works with consortia of various types and sizes, and welcomes discussion with all consortium managers. COUNTER-compliant usage statistics are provided for each institution. The benefits for the consortium include discounts on list price. Members have the flexibility to select the publications they want to include, or FSG will work with the consortium to create customized packages.

    INDEXING FSG titles are abstracted and indexed in all the main databases including MEDLINE/Index Medicus, EMBASE/Excerpta Medica, Scopus, Clarivate’s Science Citation Index Expanded and Chemical Abstracts.

    mailto:subscriptions%40future-science-group.com?subject=

  • 13For more information contact trials@future-science-group.com

    INSTITUTIONAL TRIALS

    If you would like to trial our content, simply get in touch. Trials can be to single publications or entire collections; the choice is yours. We will work with you to decide on the best time and duration for your institution.

    During the period, you have:

    • Full-text access to the titles you select • Detailed usage statistics from our Aty